- Home
- ELAN vs ALGN Comparison
ELAN vs ALGN Comparison
Compare ELAN & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELAN
- ALGN
- Stock Information
- Founded
- ELAN 1954
- ALGN 1997
- Country
- ELAN United States
- ALGN United States
- Employees
- ELAN N/A
- ALGN N/A
- Industry
- ELAN Biotechnology: Pharmaceutical Preparations
- ALGN Industrial Specialties
- Sector
- ELAN Health Care
- ALGN Health Care
- Exchange
- ELAN Nasdaq
- ALGN Nasdaq
- Market Cap
- ELAN 10.3B
- ALGN 9.5B
- IPO Year
- ELAN 2018
- ALGN N/A
- Fundamental
- Price
- ELAN $20.50
- ALGN $130.27
- Analyst Decision
- ELAN Buy
- ALGN Buy
- Analyst Count
- ELAN 8
- ALGN 13
- Target Price
- ELAN $19.14
- ALGN $216.25
- AVG Volume (30 Days)
- ELAN 5.4M
- ALGN 1.2M
- Earning Date
- ELAN 11-05-2025
- ALGN 10-29-2025
- Dividend Yield
- ELAN N/A
- ALGN N/A
- EPS Growth
- ELAN N/A
- ALGN 0.42
- EPS
- ELAN 0.88
- ALGN 5.92
- Revenue
- ELAN $4,484,000,000.00
- ALGN $3,964,802,000.00
- Revenue This Year
- ELAN $5.72
- ALGN $2.03
- Revenue Next Year
- ELAN $4.88
- ALGN $3.31
- P/E Ratio
- ELAN $23.36
- ALGN $22.04
- Revenue Growth
- ELAN N/A
- ALGN 0.56
- 52 Week Low
- ELAN $8.02
- ALGN $122.00
- 52 Week High
- ELAN $21.76
- ALGN $246.19
- Technical
- Relative Strength Index (RSI)
- ELAN 70.76
- ALGN 45.03
- Support Level
- ELAN $20.39
- ALGN $123.02
- Resistance Level
- ELAN $20.92
- ALGN $134.98
- Average True Range (ATR)
- ELAN 0.63
- ALGN 3.22
- MACD
- ELAN 0.07
- ALGN 1.24
- Stochastic Oscillator
- ELAN 64.20
- ALGN 64.79
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
About ALGN Align Technology Inc.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.